Advertisement
Australia markets closed
  • ALL ORDS

    8,039.90
    +27.80 (+0.35%)
     
  • ASX 200

    7,796.00
    +26.60 (+0.34%)
     
  • AUD/USD

    0.6662
    +0.0003 (+0.05%)
     
  • OIL

    81.44
    +0.15 (+0.18%)
     
  • GOLD

    2,376.80
    +7.80 (+0.33%)
     
  • Bitcoin AUD

    95,731.56
    -3,263.66 (-3.30%)
     
  • CMC Crypto 200

    1,339.48
    -20.84 (-1.53%)
     
  • AUD/EUR

    0.6227
    +0.0010 (+0.16%)
     
  • AUD/NZD

    1.0866
    -0.0007 (-0.06%)
     
  • NZX 50

    11,682.39
    -89.42 (-0.76%)
     
  • NASDAQ

    19,752.30
    -156.56 (-0.79%)
     
  • FTSE

    8,220.86
    -51.60 (-0.62%)
     
  • Dow Jones

    39,134.76
    +299.90 (+0.77%)
     
  • DAX

    18,140.28
    -113.90 (-0.62%)
     
  • Hang Seng

    18,028.52
    -306.80 (-1.67%)
     
  • NIKKEI 225

    38,596.47
    -36.55 (-0.09%)
     

Company News for May 10, 2023

  • Shares of Duke Energy Corporation (DUK) declined 0.9% after the company reported first-quarter 2023 earnings of $1.20 per share, missing the Zacks Consensus Estimate of $1.29 per share.

  • Lumentum Holdings Inc.’s (LITE) shares fell 4% after the company reported third-quarter fiscal 2023 earnings of $0.75 per share, lagging the Zacks Consensus Estimate of $0.83 per share.

  • Shares of Atkore Inc. (ATKR) gained 0.5% after the company reported second-quarter fiscal 2023 earnings of $4.87 per share, beating the Zacks Consensus Estimate of $4.11 per share.

  • bluebird bio, Inc.’s (BLUE) shares jumped 12.6% after the company reported first-quarter 2023 earnings of $0.21 per share, surpassing the Zacks Consensus Estimate of a loss of $0.54 per share.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Duke Energy Corporation (DUK) : Free Stock Analysis Report

bluebird bio, Inc. (BLUE) : Free Stock Analysis Report

Lumentum Holdings Inc. (LITE) : Free Stock Analysis Report

Atkore Inc. (ATKR) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research